{"database": "lobbying", "table": "lobbying_activities", "rows": [[2771995, "bf12bec3-e9b0-45e5-9e2f-70326d96ed28", "Q1", "AMERICAN UROLOGICAL ASSOCIATION", 90352, "AMERICAN UROLOGICAL ASSOCIATION", 2022, "first_quarter", "MMM", "Reduce regulatory burdens (e.g., MACRA implementation, prior authorizations, step-therapy) and promote practice sustainability during the COVID-19 public health emergency and beyond; Advocate to expand access to telehealth services as an alternative health care delivery model in urology to address access to care and health care equity; Preserve the appropriate use of the in-office ancillary services exception (IOASE) to the Stark Law; Advocate for the full continuum of care for prostate cancer survivorship;", "HOUSE OF REPRESENTATIVES,SENATE", null, 109000, 0, 0, "2022-04-12T11:35:39-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2771995"], "units": {}, "query_ms": 0.3808538895100355, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}